Hitachi High-Tech

Roche (SWX: RO), a major Swiss pharmaceutical company, has renewed its 46-year partnership with Japan’s Hitachi High-Tech (TYO: 6501) for an additional 10 years to develop innovative diagnostic solutions. This long-standing collaboration has led to an annual impact of over 21 billion in-vitro diagnostic tests, facilitated by more than 84,000…